BridgeMD
New treatment option for Transcranial Direct Current Stimulation
Official title Cumulative and Booster Effects of Multisession Prefrontal Transcranial Direct Current Stimulation in Adolescents With ASD
ClinicalTrials.gov ID: NCT05492032
What this study is testing
- What it's testing
- Autism spectrum disorder (ASD) is a pervasive and lifelong developmental disorder that currently affects 1 in 54 children. Individuals with autism are often severely impaired in communication, social skills, and cognitive functions.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 21
You may be able to join if
- Individuals who are confirmed by a clinical psychologist based on the Diagnostic and Statistical Manual of Mental Disorders-5th Ed (DSM-V) criteria...
- Individuals with ASD who are comorbid with ADHD symptoms will be included if they were willing to abstain from the use of these medications at least...
- In view of the fact that neuroadaptation to antipsychotics typically occurs within six months, potential participants who are prescribed...
You likely can't join if
- Individuals without a confirmed diagnosis from the clinical psychologist, with a history of other neurological and psychiatric disorders and head...
- In view of the possibility of seizure induction by tDCS, potential ASD participants comorbid with epilepsy will be excluded.
- Potential participants comorbid with mood or anxiety disorders will also be excluded.
The study team makes the final eligibility decision.
Where it's taking place
- Hung Hom, Kowloon, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 21 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hung Hom, Kowloon, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.